Covered Stock (Coverage)
Definition of 'Covered Stock (Coverage)'A stock that is monitored or covered by an analyst at a brokerage firm for the purpose of issuing research reports that are disseminated to the firm's clients. Upon commencement of coverage, the analyst will usually publish an "initiating coverage" report on the stock, and subsequently issue periodic updates. |
|
Investopedia explains 'Covered Stock (Coverage)'The number of analysts covering a stock can vary widely. While widely held blue chips may be covered by as many as 30 to 40 analysts, small companies that are not well-known may only be covered by one or two analysts. An analyst who stops covering a stock will generally issue a "discontinuing coverage" report. |
Related Definitions
Articles Of Interest
-
Finding Undiscovered Stocks
Wall Street tends to focus on large cap stocks, leaving other stocks under-followed and undervalued. -
Small Cap Research Can Have A Big Impact
Don't rely on Wall Street analysts for information on these stocks. -
Why There Are Few Sell Ratings On Wall Street
We outline reasons that may show why enforcing more sell ratings isn't guaranteed to increase Wall Street's objectivity. -
Analyst Recommendations: Do Sell Ratings Exist?
Analyst reports can be an investor's best friend - but without knowing how to read them, you won't be able to fully utilize them. -
Testing 3 Types Of Analysts
Different clients require different research reports. Which type of analyst do you need? -
Equity Valuation: The Comparables Approach
The main purpose of equity valuation is to estimate a value for a firm or security. There are three primary equity valuation models: the discounted cash flow (DCF), cost and comparable approaches. ... -
Weighted Average Cost Of Capital (WACC)
Weighted average cost of capital may be hard to calculate, but it's a solid way to measure investment quality -
Understanding And Playing The Dow Jones Industrial Average
Learn strategies for investing in this price-weighted index and how to interpret its movements. -
Seadrill Still In Motion, But Delivering Better Utilization And Dividends
Still an aggressively-run company, Seadrill offers highly leveraged exposure to the growing offshore drilling market. -
AstraZeneca Looks To Fish Oil To Round Out Its Cardio Portfolio
AstraZeneca validates the purified fish oil concept, but not at an especially high price.
Free Annual Reports